Atlas Trials

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Clinical trial NCT00104780 · UNKNOWN

Trial details

NCT number
NCT00104780
Sponsor
Epimmune
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2004-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.